EUVIMEDEUVIMED entdecken
Crossref

Use of Baloxavir Marboxil Post-Exposure Prophylaxis to Halt an Influenza A(H3) Outbreak in a College Sports Team, November 2024

Noah Kojima iD, Annabelle de St Maurice iD, Earl J Erezo, Erika Yanez, Elizabeth Traub, Allison Joyce iD, Amy Marutani, Nicole Green, Sharon Balter, Sheree R Poitier, Jan King

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciaf148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Noah Kojima und 10 weiteren Autor:innen. Beteiligte Einrichtung: Los Angeles County Department of Public Health, Community and Field Services Division, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Influenza, Human, Post-Exposure Prophylaxis, Antiviral Agents, Dibenzothiepins. Die Arbeit nennt 5 Literaturangaben. Gefördert von: Epidemiology and Laboratory Capacity Program (grant, cooperative agreement, Public Health Emergency Preparedness Program (cooperative agreement.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Baloxavir marboxil is approved for influenza treatment and post-exposure prophylaxis (PEP). There are limited real-world examples of its use in influenza outbreaks. Here, we describe the use of baloxavir marboxil as PEP to halt an influenza outbreak among a college sports team during the 2024–2025 influenza season.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanPost-Exposure ProphylaxisAntiviral AgentsDibenzothiepinsDisease OutbreaksMorpholinesPyridonesTriazinesThiepinsHumansUniversitiesMaleInfluenza A virusSportsYoung AdultFemale

Stichwörter der Autor:innen

baloxavirchemoprophylaxisinfluenzainfluenza post-exposure prophylaxisoutbreak management

Substanzen

baloxavirAntiviral AgentsDibenzothiepinsMorpholinesPyridonesTriazinesThiepins

Autor:innen und Institutionen

  • Los Angeles County Department of Public Health, Community and Field Services Division, Los Angeles, California, USA.
  • Los Angeles County Department of Public Health, Acute Communicable Diseases Control Program, Los Angeles, California, USA.
  • Los Angeles County Department of Public Health, Public Health Laboratory, Los Angeles, California, USA.

ORCID-Profile: Noah Kojima, Annabelle de St Maurice, Allison Joyce

Förderung

  • Epidemiology and Laboratory Capacity Program (grant
  • cooperative agreement
  • Public Health Emergency Preparedness Program (cooperative agreement
  • CDC

Zitieren

APA

Kojima, N., de St Maurice, A., Erezo, E. J., Yanez, E., Traub, E., Joyce, A., Marutani, A., Green, N., Balter, S., Poitier, S. R., & King, J. (2026). Use of Baloxavir Marboxil Post-Exposure Prophylaxis to Halt an Influenza A(H3) Outbreak in a College Sports Team, November 2024. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf148

Vancouver

Kojima N, de St Maurice A, Erezo EJ, Yanez E, Traub E, Joyce A, et al. Use of Baloxavir Marboxil Post-Exposure Prophylaxis to Halt an Influenza A(H3) Outbreak in a College Sports Team, November 2024. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciaf148

BibTeX
@article{Kojima2026,
  author = {Kojima, Noah and de St Maurice, Annabelle and Erezo, Earl J and Yanez, Erika and Traub, Elizabeth and Joyce, Allison and Marutani, Amy and Green, Nicole and Balter, Sharon and Poitier, Sheree R and King, Jan},
  title = {Use of Baloxavir Marboxil Post-Exposure Prophylaxis to Halt an Influenza A(H3) Outbreak in a College Sports Team, November 2024},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciaf148}
}
Kostenlos starten →